B-Cell Lymphomas Coverage from Every Angle

Patrizia Mondello, MD, PhD, on the Effect of New Genetic Findings on Treatment of Relapsed Follicular Lymphoma

Posted: Sunday, December 11, 2022

Patrizia Mondello, MD, PhD, of the Mayo Clinic, discusses a subset of patients with follicular lymphoma (FL) who have a poor prognosis. Dr. Mondello and her colleague found that FLs with high levels of IRF4 expression are associated with a suppressive tumor microenvironment, and selective IRF4 silencing restores antilymphoma T-cell immunity. How this gene controls tumor immunity warrants further investigation that may eventually lead to the development of precision therapies for this population.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.